Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. 1995

C J Packard, and A Gaw, and T Demant, and J Shepherd
Institute of Biochemistry, Glasgow Royal Infirmary, UK.

A multicompartmental model has been devised to explain apolipoprotein B (apoB) kinetics in very low density lipoprotein subfractions (VLDL1 Sf 60-400 and VLDL2 Sf 20-60), intermediate density (IDL Sf 12-20) and low density lipoproteins (LDL Sf 0-12). Normal and hyperlipemic subjects were given tracer doses of 131I-labeled VLDL1 and 125I-labeled VLDL2 and the metabolism of apoB in VLDL1, VLDL2, IDL, and LDL was followed over a period of 13 days. VLDL1 apoB and VLDL2 apoB clearance curves had an initial shoulder, a rapid decay, and a 'tail' of slowly metabolized lipoprotein. ApoB derived from VLDL1 appeared in IDL over 10-50 h and exhibited bi-exponential decay that was attributed to the presence of two metabolically distinct species. A further compartment was required to explain the observation that a substantial proportion of apoB from VLDL2 appeared and disappeared from the IDL density range faster than apoB derived from VLDL1 delipidation. Both of the more rapidly removed IDL species gave rise to LDL apoB that was also modeled as a heterogeneous entity with two plasma compartments. The final model, which has much in common with previous versions (M. Berman et al. 1978. J. Lipid Res. 19: 38-56), a multi-step delipidation pathway and slowly metabolized remnant compartments in VLDL, incorporates parallel delipidation routes in VLDL2, IDL, and LDL. These parallel pathways linked kinetic heterogeneity in VLDL with that in IDL and LDL.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D053419 Lipoproteins, IDL A mixture of very-low-density lipoproteins (VLDL), particularly the triglyceride-poor VLDL, with slow diffuse electrophoretic mobilities in the beta and alpha2 regions which are similar to that of beta-lipoproteins (LDL) or alpha-lipoproteins (HDL). They can be intermediate (remnant) lipoproteins in the de-lipidation process, or remnants of mutant CHYLOMICRONS and VERY-LOW-DENSITY LIPOPROTEINS which cannot be metabolized completely as seen in FAMILIAL DYSBETALIPOPROTEINEMIA. Broad-beta Lipoprotein,Floating beta-Lipoprotein,Intermediate Density Lipoprotein,Intermediate-Density Lipoprotein,alpha2-Very-Low-Density Lipoprotein,alpha2-Very-Low-Density Lipoproteins,beta-VLDL Lipoprotein,beta-Very-Low-Density Lipoprotein,beta-Very-Low-Density Lipoproteins,Broad-beta Lipoproteins,Floating beta-Lipoproteins,Intermediate Density Lipoproteins,Intermediate-Density Lipoproteins,Lipoprotein, IDL,Lipoproteins, Intermediate Density,alpha2-VLDL,alpha2-VLDL Lipoprotein,beta-VLDL,beta-VLDL Lipoproteins,Broad beta Lipoprotein,Broad beta Lipoproteins,Density Lipoprotein, Intermediate,Floating beta Lipoprotein,Floating beta Lipoproteins,IDL Lipoprotein,IDL Lipoproteins,Lipoprotein, Broad-beta,Lipoprotein, Intermediate Density,Lipoprotein, Intermediate-Density,Lipoprotein, alpha2-VLDL,Lipoprotein, alpha2-Very-Low-Density,Lipoprotein, beta-VLDL,Lipoprotein, beta-Very-Low-Density,Lipoproteins, Broad-beta,Lipoproteins, Intermediate-Density,Lipoproteins, alpha2-Very-Low-Density,Lipoproteins, beta-VLDL,Lipoproteins, beta-Very-Low-Density,alpha2 VLDL,alpha2 VLDL Lipoprotein,alpha2 Very Low Density Lipoprotein,alpha2 Very Low Density Lipoproteins,beta VLDL,beta VLDL Lipoprotein,beta VLDL Lipoproteins,beta Very Low Density Lipoprotein,beta Very Low Density Lipoproteins,beta-Lipoprotein, Floating,beta-Lipoproteins, Floating

Related Publications

C J Packard, and A Gaw, and T Demant, and J Shepherd
June 1997, Metabolism: clinical and experimental,
C J Packard, and A Gaw, and T Demant, and J Shepherd
August 1993, Biochemical Society transactions,
C J Packard, and A Gaw, and T Demant, and J Shepherd
September 1980, Journal of theoretical biology,
C J Packard, and A Gaw, and T Demant, and J Shepherd
January 1979, Progress in biochemical pharmacology,
C J Packard, and A Gaw, and T Demant, and J Shepherd
September 1987, Metabolism: clinical and experimental,
C J Packard, and A Gaw, and T Demant, and J Shepherd
January 1994, Journal of clinical laboratory analysis,
C J Packard, and A Gaw, and T Demant, and J Shepherd
November 1989, Journal of lipid research,
C J Packard, and A Gaw, and T Demant, and J Shepherd
September 1980, Atherosclerosis,
C J Packard, and A Gaw, and T Demant, and J Shepherd
January 1985, Monographs on atherosclerosis,
Copied contents to your clipboard!